53% AFTER Buyouts Are Announced Because of an anomaly that exists in one tiny "sub-sector" of the markets, you can make a killing AFTER buyout deals are announced. Since November 2007, this anomaly has a perfect track record. 20 announcements. 20 winners. The largest gain was over 400%... The average was 53%. The average holding period was less than 7 weeks. Best of all, there are estimated to be about 12 of these deals over the next 12 months. You can access this research for 50% off the regular rate... but you must let us know by Monday, June 29th. Dear Reader, It's no secret that stock buyouts are one of the best ways to make money in the financial markets. When InBev recently made an offer to buy Anheuser Busch for example, investors made 94%. When Dow Chemical recently bought Rohm & Haas, investors made as much as 179% gains. Predicting WHICH stocks are likely to be bought out is almost impossible. And even if you can somehow predict which company will be bought out, you often have to wait years for a potential deal to emerge. learned from a Ph.D. trading expert... Because of an anomaly that exists in one tiny "sub-sector" of the markets, you can actually make a fortune on stock buyouts, and you don't have to make a single investment until AFTER a buyout deal has been announced. In other words: You wait for a buyout deal to be announced... THEN you can make a simple investment, and collect gains of 5% to 400%... in a matter of weeks. And get this: Over the past two years, this investment anomaly has a perfect track record:
What's more, we estimate there are about 12 deals you could capitalize on over the next 12 months... That's 12 more opportunities to see returns of 5%... with the potential to occasionally see 100%, 200%, 300%, or more, in as little as one week. Let me show you what I mean... of a rich doctor I first learned about this secret from a Ph.D. trading expert. His name is Dr. George Huang. Dr. Huang is one of the smartest people I know. He spent the better part of the last decade working in Academic institutions, as a contractor for the U.S. government, and with private biotech firms. This market anomaly is something he uncovered while working with the National Institute of Health (NIH). As soon as he figured it out, Dr. Huang began using this secret personally, in his own trading account, to rack up huge gains very quickly... typically in 7 weeks or less. Dr. Huang says: "I think everyone knows there's big money to be made in buyouts. The problem is, it's typically corporate insiders who pocket all the gains.410% in 6 weeks? 47% in 12? That may sound impossible, but Dr. Huang even showed me his personal trading receipts to prove it. The following results aren't "cherry-picked" either. These numbers represent all 5 trades he's made personally, over the past 36 months. Notice how each one made money... and how fast the profits came in:
What kind of money does this translate into? Well, if you invested just $5,000 in each trade you'd now have around $26,300 in pure profit. During that time, keep in mind, the stock market averages LOST about 25%! So... What exactly, is this anomaly in the markets... and how does it work to provide a perfect track record of gains... in just a matter of weeks? To understand how this anomaly works, you have to understand the basics of how stock "buyouts" work. In short, one company proposes to buy every outstanding share of a smaller company... at a price that's higher than the current value. For example, in a recent buyout in the software industry, Emerson Electric offered to buy Norwegian firm, Roxar, for $5.20 a share. At the time of the offer, Roxar was trading for around $3 a share. But the minute the deal was announced, shares of Roxar soared to $5.20. Just like that, the easy money was gone. Unless you were a "well-connected" investor... or somehow knew this buyout was taking place, there's no way you could have profited from the situation... situation is very different You see, when buyout deals take place in the sophisticated world of new drug treatments and medical devices, the situation is a little different. And this tiny "sub-sector" of the markets offers you the opportunity to make a ton of money... on some of the safest and most predictable share price moves in the world. This happens, ironically, because buyout deals in the medical world are typically very complex. They involve many "intangible" assets: such as drug or device patents, complicated partnership deals, yet-to-be-approved new technologies, and sophisticated intellectual property rights. Because it takes more time to evaluate a deal in the medical world than, say, the software industry, there's a DELAY in the share price move AFTER a buyout is announced. Sometimes it lasts 2-3 days. Sometimes it lasts 2-3 weeks. For example, when Gen-Probe recently announced an offer to buy British drug maker Tepnel for $27 a share, the stock price of Tepnel went from $14 to $16 after the announcement was made. But here's the thing. The price of Tepnel didn't jump all the way to near $27 until 7 days AFTER the announcement was made. If you knew about this DELAY, you could have made a huge 69% gain in just 7 days. The point is, this delay occurs EVERY SINGLE TIME a big medical buyout deal is announced. Since November 2007, out of 20 buyouts... the delay occurred ALL 20 times. And if you know how to take advantage of it, you can make an absolute fortune. Here's what I mean... On September 10, Eli Lilly announced an offer to buy a company called Imclone for $70 a share. After the announcement was made, Imclone's share price went from $57 to $59. But Imclone's share price didn't jump to near $70 until 5 weeks AFTER the announcement was made. If you knew about this anomaly in the medical markets, you could have make a whopping 115% AFTER the buyout was announced.A small $5,000 investment would have grown to more than $11,500. It took just 4 weeks. But that's not all... King Pharmaceuticals announced an offer to buy Alpharma for $37 a share. After the announcement was made, Alpharma's share price went from $30 to $31. But again, Alpharma's share price didn't jump to near $37 until 8 weeks AFTER the announcement was made. You could have made an 83% gain AFTER the buyout was announced... and in just 8 weeks time.That's 2 opportunities in the very same month! But here's the incredible part... The two plays I just showed you weren't just successful "case studies" we found after the fact... ACTUAL gains You see... What I haven't told you is that we've been quietly sharing Dr. Huang's buyout strategy with a small group of interested readers... to see if it would work on a wider scale. In fact, the Imclone and Alpharma buyouts I just described were just TWO plays Dr. Huang recommended to our readers, under this strategy. But of course, anyone can get "lucky" once, maybe even twice, right? The real question is... Can Dr. Huang's strategy perform consistently... over the "long haul"? Actually, it already has... incredible trading breakthroughs I've ever seen So far, Dr. Huang has made a total of 6 recommendations to S&A readers using this strategy. The first was in September 2008... the most recent one this May. That's about 7 months of "real-world" application. And so far, EVERY SINGLE buyout scenario has been a winner. Here are the actual plays in order (some are still open... and still gaining)...
Not a single loser. If you invested just $5,000 in each play you'd now have more than $18,100 in pure profit. In just 7 months. Yes. Dr. Huang's trading recommendations are working in the "real world" far above our highest expectations. Here's what a few S&A readers who are following this new strategy are saying: "Dr. George, great call on Genentech... I pocketed $22,000!"But, one thing you might be wondering is... you say it is? Definitely. You see, this strategy is so simple to execute, you can sum it up in 3 EASY steps: 1. Just WAIT for a buyout deal to be announced. Dr. Huang will alert you as soon as any deal comes over the wire...Of course, no investment is 100% guaranteed... There are no "sure things" in the investment world. But keep in mind, one of the great things about Dr. Huang's strategy is how consistent and reliable it's proven to be... Remember: This strategy has been successful 20 out of the past 20 times, since November 2007.But here's the thing. For the past 7 months, Dr. Huang has kept this secret strategy reserved for a "niche" group of S&A readers. That is, until now. My name is Brian Hunt. I'm the Editor in Chief of Stansberry & Associates Investment Research. The past 7 months has been a very exciting time at S&A Research. During this time, I've been working closely with Dr. Huang, overseeing his medical buyout strategy. If cashing in on these very safe and extremely lucrative opportunities interests you, I encourage you to take a no-risk look at Dr. Huang's trading advisory newsletter called the S&A FDA Report. We began the FDA Report about a year ago as a way to capitalize on the numerous "inefficiencies"... "glitches"... and "anomalies" that exist in the medical sector. What kind of opportunities am I talking about? Well... For example, during last fall's major financial collapse, while most investors were losing their shirts, Dr. Huang discovered a pricing "anomaly" in the medical sector that enabled readers to see 70% in 14 days with a company called Intermune and 146% in just 7 weeks, with a company called Dendreon.Of course, what really matters is that FDA Report subscribers are raking in gains: "I made 299% on SSPI! Thanks for another FDA winner!"Of course, the aspect of the FDA Report we're most excited about right now is the buyout strategy Dr. Huang has been showing our readers over the past 7 months. As I mentioned, this is the first time that Dr. Huang has ever invited anyone to specifically join him in capitalizing on these types of deals. But before I show you how to get started there's one more thing I think you'll want to know about these deals, which could put even more money in your pocket... One of the great things about these medical buyout deals is the potential for something called a buyout "bonus." A buyout bonus is extra money medical companies will actually pay you for taking part in these buyout deals... ON TOP of any money you make as a result of the delay. Let me explain... Take, for example, the Indevus buyout, a play Dr. Huang recommended to his readers back in January. Endo Pharmaceuticals offered to buy Indevus for $4.50 a share. Dr. Huang's readers had the chance to see a 74% gain in just 4 weeks time (some readers saw gains as high as 186%). But what I haven't told you is that AFTER the deal closes, Endo Pharmaceuticals has offered to pay shareholders an additional $3 PER SHARE, just for taking part in the deal! Yes, you read that right: You can often get paid a huge instant dividend... on top of the super-safe gains of up to 100% or more. Why does this happen? Well, often, a company agrees to a buyout price... plus cash, to sweeten the deal for shareholders. So, not only did some readers make as much as 186% in 4 weeks on the Indevus deal, but they can expect to get an additional 67% "buyout bonus"! Amazing right? These buyout bonuses don't happen every time, but when they occur, they can be very rewarding... For example... Lev Pharmaceuticals recently got bought out for $2.25 a share. But shareholders can get an additional $1 on top of that when the deal closes. That's an extra 55%!So, not only can you make a killing on the buyout anomaly, but you can also get paid additional cash in the form of these "buyout bonuses." Can you see why I think this is, hands down, one of the most incredible trading breakthroughs ever devised? As soon as you become a subscriber to the FDA Report, we will give you instant access to a full report detailing his next buyout play. You see, there's an extremely safe and lucrative deal you can cash in on RIGHT NOW. For obvious reasons, I can't get into the full details of Dr. Huang's new recommendation here. What I can tell you is that the deal involves a tiny biotech firm and a giant Pharmaceutical company. The deal closes in just a few short weeks. Dr. Huang estimates you could make 45% over that time. It will probably be the quickest and safest 45% you make all year. As soon as you let me know you'd like to try this Research, you will get Dr. Huang's recommendation with full instructions, right away. Then, simply follow Dr. Huang's instructions, and see the gains pile up over the next few weeks. Of course, like I said before, no investment is 100% guaranteed. But again, Dr. Huang's strategy has, so far, proven itself to be extremely safe and consistent. Going forward, Dr. Huang will send you the details on newest buyout deal in the medical community about once a month. Remember how easy it is: 1. Just WAIT for a buyout deal to be announced. Dr. Huang will alert you as soon as any deal comes over the wire...Don't forget: Over the past two years, this investment anomaly has a perfect track record:
So, how much does FDA Report cost? Well, considering the perfect track record, and what we pay for Dr. Huang's services, we should probably charge around $5,000 per year, as we do for our other health sector research. But so far, we've kept the price for one year of FDA Report research at a much lower rate: $2,400. That's the beauty of getting Dr. Huang's research as part of a subscription service, rather than having to pay him on your own. You can get his research at a fraction of the price he would normally charge an individual client. Plus, for a narrow window of time, there's a way for you to get the FDA Report for HALF-OFF this low rate. Just let us know before Monday, June 29th that you'd like to give the FDA Report a try and you'll pay just $1,200 for an entire year. You'll have 90 DAYS to decide whether Dr. Huang's research is right for you. I think this is an outrageously cheap price, for this level of research, which is normally available only to investors in expensive hedge funds and private placements. Many subscribers feel the same way: Made more than enough to pay for the subscription price!Is it worth $1,200 a year to receive a dozen or so safe and profitable "buyout" recommendations a year... with a perfect track record? I certainly think so – I expect you could make back the subscription cost and more on your very first play. But of course, you'll have to judge for yourself. If for whatever reason you want to cancel your subscription in the first ninety days, just let us know. We'll return your subscription price (minus a 10% refund fee). Even after the 90 days is up you can still get a prorated refund (minus a 10% refund fee). You see, we want to avoid "tire-kickers" - the folks who sign up without any intention of actually paying. That's why we've instituted this refund charge. Here's what you'll receive as an S&A FDA Report subscriber: Special Report: The Next Big Buyout. This members-only report details Dr. Huang's latest buyout recommendation – an extremely safe and lucrative deal you can get in on RIGHT NOW. This report also represents your "buyout anomaly" trading bible. You'll learn the full details on this unique situation... and the secrets behind Dr. Huang's proprietary buyout trading strategy. Read this first, before you review anything else.To take advantage of this unique opportunity, Subscribe Now Sincerely, Brian Hunt Editor In Chief, Stansberry & Associates June 2009 P.S. Don't forget... for a narrow window of time, there's a way for you to get the FDA Report for HALF-OFF the regular rate. You'll pay just $1,200 for an entire year, and you'll have 90 DAYS to decide whether Dr. Huang's research is right for you. This deal expires on Monday, June 29th. See the order form for more details. |